Washington State University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Washington State University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013501
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Washington State University (WSU) is an educational university that provides educational and research programs. The university offers undergraduate, graduate, professional, international and online courses. It provides educational programs in the areas of agricultural, environmental and natural resource sciences, anthropology, communication, engineering and architecture, nursing, veterinary science and geology among others. WSU researchers work with federal and state agencies, national laboratories, business and civic enterprises. It assists in transfer of technology, proprietary information and inventions from WSU laboratories into the marketplace. WSU is headquartered in Pullman, Washington, the US.

Washington State University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Washington State University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington State University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington State University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Washington State University, Medical Devices Deals, 2011 to YTD 2017 9
Washington State University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Washington State University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Botanisol Enters into Collaboration Agreement with Washington State University 11
Cancer Targeted Technology Enters into Research And License option Agreement with Washington State University 12
Licensing Agreements 13
AAVogen Receives Technology from Washington State University 13
Washington State University – Key Competitors 14
Washington State University – Key Employees 15
Washington State University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
May 15, 2017: WSU researchers deliver first ‘nanotherapeutics’ to tumor 17
Feb 09, 2016: WSU researchers see helpful protein causing cancer 18
Product News 19
Nov 29, 2016: Researchers develop novel wound-healing technology 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Washington State University, Pharmaceuticals & Healthcare, Key Facts 2
Washington State University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington State University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington State University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington State University, Deals By Therapy Area, 2011 to YTD 2017 8
Washington State University, Medical Devices Deals, 2011 to YTD 2017 9
Washington State University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Botanisol Enters into Collaboration Agreement with Washington State University 11
Cancer Targeted Technology Enters into Research And License option Agreement with Washington State University 12
AAVogen Receives Technology from Washington State University 13
Washington State University, Key Competitors 14
Washington State University, Key Employees 15
Washington State University, Subsidiaries 16

★海外企業調査レポート[Washington State University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzuki Motor Corporation (7269):企業の財務・戦略的SWOT分析
    Suzuki Motor Corporation (7269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • L.L. Bean, Inc.:企業の戦略・SWOT・財務情報
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Payton Planar Magnetics Ltd (PAY):企業の財務・戦略的SWOT分析
    Payton Planar Magnetics Ltd (PAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SmartCool Systems Inc (SSC):電力:M&Aディール及び事業提携情報
    Summary SmartCool Systems Inc (SmartCool Systems) is a clean technology company that manufactures and sells energy and cost reduction technologies. The company’s products include ECO3, ESM, and soft solutions. Its ECO3 and ESM are retrofit technologies that reduce the energy consumption of compresso …
  • Arno Therapeutics Inc (ARNI)-製薬・医療分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • House Foods Group Inc:企業の戦略・SWOT・財務分析
    House Foods Group Inc - Strategy, SWOT and Corporate Finance Report Summary House Foods Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MedImmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune Ltd (MedImmune), formerly Cambridge Antibody Technology Ltd, is a subsidiary of AstraZeneca Plc, is a research and development company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respi …
  • Xcel Energy Inc (XEL)-石油・ガス分野:企業M&A・提携分析
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Alliqua BioMedical Inc (ALQA)-製薬・医療分野:企業M&A・提携分析
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial …
  • BDO International Ltd:企業の戦略的SWOT分析
    BDO International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Covance Inc:医療機器:M&Aディール及び事業提携情報
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • Inspire Medical Systems Inc (INSP):医療機器:M&Aディール及び事業提携情報
    Summary Inspire Medical Systems Inc (Inspire) is a medical device company that manufactures and markets healthcare implants. The company offers implanted neurostimulation device. It offers product is used for treatment of obstructive sleep apnea. Inspire uses neurostimulation technologies. The compa …
  • GlobalData plc (PRO):企業の財務・戦略的SWOT分析
    Summary GlobalData plc (GD), formerly Progressive Digital Media Group plc is a media company that offers premium business information, research services and marketing solutions for senior level decision makers. The company provides solutions such as intelligence center, consulting and report store. …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • DLF Limited:企業の戦略・SWOT・財務情報
    DLF Limited - Strategy, SWOT and Corporate Finance Report Summary DLF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • A&E Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary A&E Medical Corp (A&E Medical), a subsidiary of Vance Street Capital LLC, is a medical device company that manufactures and distributes surgical equipment. The company offers products such as temporary cardiac pacing wires, sternotomy sutures, lluminated vein harvest retractors, electrosurgi …
  • New York City Health and Hospitals Corp:企業の戦略的SWOT分析
    New York City Health and Hospitals Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Sociedad Minera El Brocal SAA (BROCALC1):企業の財務・戦略的SWOT分析
    Sociedad Minera El Brocal SAA (BROCALC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sprint Corporation:企業の戦略・SWOT・財務情報
    Sprint Corporation - Strategy, SWOT and Corporate Finance Report Summary Sprint Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆